Background: Kaposiform hemangioendothelioma (KHE) is a rare, locally aggressive vascular tumor of infancy that may be complicated by Kasabach-Merritt phenomenon (KMP), a potentially fatal consumptive coagulopathy. Cervicothoracic involvement is particularly challenging because of the risk of airway compromise and involvement of critical structures. We present a rare case of cervicothoracic KHE with KMP, highlighting the diagnostic challenge, life-threatening complications, and need for individualized multidisciplinary management.
Case Report: A 3-month-old preterm female presented with a rapidly enlarging violaceous cervicothoracic mass initially considered a hemangioma, followed by severe respiratory distress, bradycardia, and cardiac arrest requiring resuscitation and intubation. Laboratory evaluation revealed profound thrombocytopenia, hypofibrinogenemia, elevated D-dimer, anemia, and coagulopathy. Imaging demonstrated an extensive infiltrative vascular mass involving multiple deep neck spaces with carotid encasement and significant airway compression. Corticosteroids, vincristine, and sirolimus were administered, with bleomycin sclerotherapy as an adjunct. Management was complicated by recurrent bacterial and fungal infections, treatment interruptions, profound cytopenias, and prolonged ventilator dependence. KMP subsequently resolved with platelet recovery and normalization of fibrinogen. Despite persistent residual tumor on later imaging, respiratory status progressively improved, allowing transition to room air and eventual discharge on continued therapy.
Summary: This case highlights the rarity and complexity of KHE-associated KMP in a critical cervicothoracic location. Beyond controlling tumor size, successful management required simultaneous attention to consumptive coagulopathy, airway preservation, infection, treatment toxicity, and procedural risk. It underscores that in rare vascular tumors, clinical decisions must extend beyond standardized algorithms toward individualized, multidisciplinary care guided by the patient’s evolving hematologic, anatomic, and functional status.

